从良性前列腺增生到男性下尿路症状：欧洲泌尿外科学会指南20年历程 - Suppr

From BPH to male LUTS: a 20-year journey of the EAU guidelines.

作者信息

Gravas Stavros, Malde Sachin, Cornu Jean-Nicolas, Gacci Mauro, Gratzke Christian, Herrmann Thomas R W, Karavitakis Markos, Mamoulakis Charalampos, Rieken Malte, Sakalis Vasileios I, Schouten Natasha, Smith Emma J, Speakman Mark J, Tikkinen Kari A O, Alivizatos Gerasimos, Bach Thorsten, Bachmann Alexander, Descazeaud Aurelian, Desgrandchamps François, Drake Marcus, Emberton Mark, Kyriazis Iason, Madersbacher Stephan, Michel Martin C, N'Dow James, Perachino Massimo, Plass Karin, Rioja Sanz Carlos, Umbach Roland, de Wildt Michel, Oelke Matthias, de la Rosette Jean J M C H

机构信息

Department of Urology, Medical School, University of Cyprus, Nicosia, Cyprus.

Department of Urology, Guy's and St Thomas' NHS Foundation Trust, London, UK.

出版信息

Prostate Cancer Prostatic Dis. 2024 Mar;27(1):48-53. doi: 10.1038/s41391-023-00700-3. Epub 2023 Jul 24.

DOI:10.1038/s41391-023-00700-3

PMID:37488274

Abstract

摘要

相似文献

From BPH to male LUTS: a 20-year journey of the EAU guidelines.从良性前列腺增生到男性下尿路症状：欧洲泌尿外科学会指南20年历程

Prostate Cancer Prostatic Dis. 2024 Mar;27(1):48-53. doi: 10.1038/s41391-023-00700-3. Epub 2023 Jul 24.

From BPH to male LUTS: a 20-year journey of the EAU guidelines.从良性前列腺增生到男性下尿路症状：欧洲泌尿外科学会指南的20年历程。

Prostate Cancer Prostatic Dis. 2024 Jun;27(2):172. doi: 10.1038/s41391-023-00773-0. Epub 2023 Dec 13.

Poor clinical guideline adherence and inappropriate testing for incident lower urinary tract symptoms associated with benign prostatic hyperplasia.临床指南遵循度差，对与良性前列腺增生相关的新发下尿路症状进行不适当的检查。

Prostate Cancer Prostatic Dis. 2022 Feb;25(2):269-273. doi: 10.1038/s41391-021-00435-z. Epub 2021 Sep 20.

[Guide dedicated to general practitioner for the management of lower urinary tract symptoms related to benign prostatic hyperplasia].[全科医生管理良性前列腺增生相关下尿路症状指南]

Prog Urol. 2015 Jun;25(7):404-12. doi: 10.1016/j.purol.2015.02.008. Epub 2015 Apr 2.

The Epidemiology of Benign Prostatic Hyperplasia Associated with Lower Urinary Tract Symptoms: Prevalence and Incident Rates.与下尿路症状相关的良性前列腺增生症的流行病学：患病率和发病率

Urol Clin North Am. 2016 Aug;43(3):289-97. doi: 10.1016/j.ucl.2016.04.001.

Impact of metabolic syndrome-related factors on the development of benign prostatic hyperplasia and lower urinary tract symptoms in Asian population.代谢综合征相关因素对亚洲人群良性前列腺增生和下尿路症状发生发展的影响。

Medicine (Baltimore). 2019 Oct;98(42):e17635. doi: 10.1097/MD.0000000000017635.

EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction.EAU 指南：非神经原性男性下尿路症状包括良性前列腺增生的评估。

Eur Urol. 2015 Jun;67(6):1099-1109. doi: 10.1016/j.eururo.2014.12.038. Epub 2015 Jan 19.

Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia.良性前列腺增生所致下尿路症状与性功能障碍关系的批判性分析。

Eur Urol. 2011 Oct;60(4):809-25. doi: 10.1016/j.eururo.2011.06.037. Epub 2011 Jun 29.

Mobile health: a promising tool for the management of male patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.移动健康：一种用于管理疑似良性前列腺增生的男性下尿路症状患者的有前景的工具。

Prostate Cancer Prostatic Dis. 2023 Dec;26(4):712-714. doi: 10.1038/s41391-023-00649-3. Epub 2023 Jan 25.

Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review.COVID-19 是否是良性前列腺增生进展和其相关症状恶化的危险因素？：系统评价。

Prostate Cancer Prostatic Dis. 2022 Mar;25(1):27-38. doi: 10.1038/s41391-021-00388-3. Epub 2021 May 18.

引用本文的文献

Step-by-step anatomical photovaporization of the prostate using 180-W XPS greenlight laser: optimizing functional outcomes through energy modulation.使用180瓦XPS绿光激光对前列腺进行逐步解剖性光汽化：通过能量调制优化功能结果。

Can J Urol. 2025 Aug 29;32(4):283-292. doi: 10.32604/cju.2025.065984.

Optilume, a minimally invasive solution for BPH and urethral stricture: what we know, what we need? an EAU endourology scoping review.Optilume，一种用于良性前列腺增生和尿道狭窄的微创解决方案：我们所知与所需？一篇欧洲泌尿外科学会腔内泌尿外科范围界定综述

BMC Urol. 2025 Aug 9;25(1):196. doi: 10.1186/s12894-025-01896-3.

One-night catheter stay after Holmium laser enucleation of the prostate: a single-center comparative study.前列腺钬激光剜除术后留置导尿管一晚：一项单中心对比研究。

Int Urol Nephrol. 2025 Jun 24. doi: 10.1007/s11255-025-04627-7.

MISTs for benign prostatic hyperplasia as first line interventional treatment: Alea iacta est?用于良性前列腺增生的微波热疗作为一线介入治疗：木已成舟？

Prostate Cancer Prostatic Dis. 2025 May 21. doi: 10.1038/s41391-025-00986-5.

Perioperative outcomes of HoLEP, ThuLEP, and TURP in patients with prostate cancer: results from the GRAND study.前列腺癌患者接受铥激光前列腺剜除术（HoLEP）、经尿道钬激光前列腺剜除术（ThuLEP）和经尿道前列腺切除术（TURP）的围手术期结果：GRAND研究结果

Prostate Cancer Prostatic Dis. 2025 May 19. doi: 10.1038/s41391-025-00980-x.

1470 nm diode laser enucleation versus bipolar transurethral resection of the prostate for the surgical management of benign prostatic hyperplasia: a randomized comparison.1470纳米二极管激光剜除术与双极经尿道前列腺切除术治疗良性前列腺增生症的手术管理：一项随机对照研究

Lasers Med Sci. 2025 May 17;40(1):226. doi: 10.1007/s10103-025-04478-9.

Combination Pharmacotherapy for Benign Prostatic Hyperplasia: Evaluation of Existing Literature on Combination Therapies for Lower Urinary Tract Symptoms Associated with BPH.良性前列腺增生的联合药物治疗：对与良性前列腺增生相关的下尿路症状联合治疗的现有文献评估

Drugs Aging. 2025 May 2. doi: 10.1007/s40266-025-01198-1.

Prostatic Artery Embolization in Elderly Comorbid Patients with Benign Prostatic Hyperplasia: Safety, Efficacy, and Predictive Factors of Clinical Failure.老年合并症良性前列腺增生患者的前列腺动脉栓塞术：安全性、有效性及临床失败的预测因素

J Pers Med. 2025 Jan 10;15(1):23. doi: 10.3390/jpm15010023.

Investigation on clinical risk factors of bladder lesion by machine learning based interpretable model.基于机器学习可解释模型的膀胱病变临床风险因素研究。

Sci Rep. 2024 Oct 16;14(1):24299. doi: 10.1038/s41598-024-75104-x.

Evaluation of Peri-Operative Outcomes after Prostatic Urethral Lift with Emphasis on Urodynamic Changes, Symptom Improvement and Sexual Function.经尿道前列腺悬吊术围手术期结局评估，重点关注尿动力学变化、症状改善及性功能

Diagnostics (Basel). 2024 Sep 24;14(19):2110. doi: 10.3390/diagnostics14192110.

本文引用的文献

A Systematic Review of Patients' Values, Preferences, and Expectations for the Diagnosis and Treatment of Male Lower Urinary Tract Symptoms.男性下尿路症状的诊断和治疗中患者的价值观、偏好和期望的系统评价。

Eur Urol. 2021 Jun;79(6):796-809. doi: 10.1016/j.eururo.2020.12.019. Epub 2021 Jan 15.

IMAGINE-IMpact Assessment of Guidelines Implementation and Education: The Next Frontier for Harmonising Urological Practice Across Europe by Improving Adherence to Guidelines.想象一下——通过提高对指南的遵从性来评估指南实施和教育的影响：通过改善对指南的遵从性来协调欧洲泌尿外科实践的下一个前沿。

Eur Urol. 2021 Feb;79(2):173-176. doi: 10.1016/j.eururo.2020.10.011. Epub 2020 Oct 29.

What Is the Required Certainty of Evidence for the Implementation of Novel Techniques for the Treatment of Benign Prostatic Obstruction?治疗良性前列腺梗阻的新技术实施所需证据的确切性如何？

Eur Urol Focus. 2019 May;5(3):351-356. doi: 10.1016/j.euf.2019.05.014. Epub 2019 Jun 14.

Adherence to EAU guidelines on penile cancer translates into better outcomes: a multicenter international study.遵循 EAU 阴茎癌指南可改善治疗结局：一项多中心国际研究。

World J Urol. 2019 Aug;37(8):1649-1657. doi: 10.1007/s00345-018-2549-3. Epub 2018 Oct 30.

Key Steps in Conducting Systematic Reviews for Underpinning Clinical Practice Guidelines: Methodology of the European Association of Urology.开展临床实践指南的系统评价的关键步骤：欧洲泌尿外科学会的方法学。

Eur Urol. 2018 Feb;73(2):290-300. doi: 10.1016/j.eururo.2017.08.016. Epub 2017 Sep 13.

Medical Treatment of Nocturia in Men with Lower Urinary Tract Symptoms: Systematic Review by the European Association of Urology Guidelines Panel for Male Lower Urinary Tract Symptoms.男性下尿路症状患者夜尿症的治疗：欧洲泌尿外科学会男性下尿路症状指南小组的系统评价。

Eur Urol. 2017 Nov;72(5):757-769. doi: 10.1016/j.eururo.2017.06.010. Epub 2017 Jun 27.

Changing Current Practice in Urology: Improving Guideline Development and Implementation Through Stakeholder Engagement.改变泌尿外科现状：通过利益相关者的参与来改进指南的制定和实施。

Eur Urol. 2017 Aug;72(2):161-163. doi: 10.1016/j.eururo.2017.02.008. Epub 2017 Feb 22.

Systematic Review of the Performance of Noninvasive Tests in Diagnosing Bladder Outlet Obstruction in Men with Lower Urinary Tract Symptoms.系统评价非侵入性检查在诊断男性下尿路症状患者膀胱出口梗阻中的性能。

Eur Urol. 2017 Mar;71(3):391-402. doi: 10.1016/j.eururo.2016.09.026. Epub 2016 Sep 27.

Efficacy and safety of botulinum toxin injection for benign prostatic hyperplasia: a systematic review and meta-analysis.肉毒杆菌毒素注射治疗良性前列腺增生的疗效与安全性：一项系统评价和荟萃分析。

Int Urol Nephrol. 2016 Jan;48(1):19-30. doi: 10.1007/s11255-015-1153-3. Epub 2015 Nov 11.

A multicenter, randomized, double-blind, placebo controlled study of onabotulinumtoxinA 200 U to treat lower urinary tract symptoms in men with benign prostatic hyperplasia.一项多中心、随机、双盲、安慰剂对照研究，评估 200U 注射用肉毒毒素 A 治疗良性前列腺增生男性下尿路症状。

J Urol. 2014 Jul;192(1):150-6. doi: 10.1016/j.juro.2014.02.004. Epub 2014 Feb 7.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

From BPH to male LUTS: a 20-year journey of the EAU guidelines.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献